Región de Coquimbo
Este organismo compró $163.615.485.813 en 102.138 órdenes de compra , sobre todo en Productos de papel / Productos de papel / Papeles comerciales y le compró principalmente a Edenred Chile Sociedad Anonima.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $9775,8 M |
| 2025 | $18,9 mil M |
| 2024 | $18 mil M |
| 2023 | $18,6 mil M |
| 2022 | $16,5 mil M |
| 2021 | $12,1 mil M |
| 2020 | $15,9 mil M |
| 2019 | $8686,2 M |
| 2018 | $6691,9 M |
| 2017 | $6275,1 M |
| 2016 | $5956,7 M |
| 2015 | $5661,5 M |
| 2014 | $3813,6 M |
| 2013 | $3891,5 M |
| 2012 | $3119,4 M |
| 2011 | $3135,7 M |
| 2010 | $1782,2 M |
| 2009 | $1810,3 M |
| 2008 | $1418,6 M |
| 2007 | $1238,6 M |
| 2006 | $319,1 M |
Gasto en remedios comprados fuera de CENABAST cada segundo semestre, y la proyección H2-2026 (estacional). En verde, el sobreprecio evitable si se comprara vía CENABAST (~27%, conservador).
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 1242125-72-SE24 | 31-12-2024 | Oftomed Limitada | Recepcion Conforme | $4.760.000 |
| 1058045-1039-SE24 | 31-12-2024 | Pharmatech Chile SpA | Recepcion Conforme | $957.950 |
| 1242125-80-SE24 | 31-12-2024 | Oftomed Limitada | Recepcion Conforme | $4.760.000 |
| 1058045-1093-SE24 | 31-12-2024 | Novofarma Service S.A. | Recepcion Conforme | $2.959.316 |
| 1058045-1161-SE24 | 31-12-2024 | Difem Laboratorios S.A. | Recepcion Conforme | $576.912 |
| 1058045-1167-SE24 | 31-12-2024 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $5.087.345 |
| 1242125-84-SE24 | 31-12-2024 | Arrendadora de Vehiculos Limitada | Recepcion Conforme | $5.859.151 |
| 1242125-85-SE24 | 31-12-2024 | Arrendadora de Vehiculos Limitada | Recepcion Conforme | $5.807.448 |
| 1240099-298-TD24 | 31-12-2024 | Histopatologia Medica SpA | Recepcion Conforme | $70.836.540 |
| 1242121-912-AG24 | 31-12-2024 | Servicio de Construccion e Ingenieria para Mineras Ingeacep SpA | Recepcion Conforme | $1.584.449 |
| 1058045-1203-SE24 | 31-12-2024 | Laboratorios Andromaco S.A. | Recepcion Conforme | $2.011.100 |
| 1058045-1204-SE24 | 31-12-2024 | Distribuidora Qualimed Limitada | Recepcion Conforme | $571.200 |
| 1058045-1205-SE24 | 31-12-2024 | Distribuidora Qualimed Limitada | Recepcion Conforme | $3.319.672 |
| 1058045-1206-SE24 | 31-12-2024 | Laboratorios Kampar S.A. | Recepcion Conforme | $1.904.000 |
| 1058045-1207-SE24 | 31-12-2024 | Bestpharma S.A. | Recepcion Conforme | $968.660 |
| 1242131-1642-TD24 | 31-12-2024 | B Braun Medical SpA | Recepcion Conforme | $29.446.788 |
| 1058045-1209-SE24 | 31-12-2024 | Laboratorio Chile S.A. | Recepcion Conforme | $2.192.706 |
| 1242121-913-TD24 | 31-12-2024 | Servicio de Construccion e Ingenieria para Mineras Ingeacep SpA | Recepcion Conforme | $284.708 |
| 1242125-90-TD24 | 31-12-2024 | Oftomed Limitada | Recepcion Conforme | $9.520.000 |
| 1058045-1210-SE24 | 31-12-2024 | Opko Chile S.A. | Recepcion Conforme | $1.067.430 |
| 1058045-1212-SE24 | 31-12-2024 | Astrazeneca S.A. | Recepcion Conforme | $1.232.245 |
| 1058045-1214-SE24 | 31-12-2024 | Guillermo Harding y Compania Limitada | Recepcion Conforme | $1.749.080 |
| 1058045-1215-SE24 | 31-12-2024 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $54.157 |
| 1058045-1216-SE24 | 31-12-2024 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $138.695 |
| 1058045-1217-SE24 | 31-12-2024 | Comercializadora e Inversiones Ghaleno Limitada | Recepcion Conforme | $4.873.050 |
| 1058045-1219-SE24 | 31-12-2024 | Difem Laboratorios S.A. | Recepcion Conforme | $860.965 |
| 1058045-1220-SE24 | 31-12-2024 | Laboratorio Chile S.A. | Recepcion Conforme | $366.639 |
| 1058045-1221-SE24 | 31-12-2024 | Tecnofarma S.A. | Recepcion Conforme | $985.856 |
| 1058045-1223-SE24 | 31-12-2024 | Laboratorios Andromaco S.A. | Recepcion Conforme | $371.280 |
| 1058045-1224-SE24 | 31-12-2024 | Exeltis Chile SpA | Recepcion Conforme | $4.165.000 |
